Skip to main content

Table 1 Clinical and pathological data for SCEO and ECOM patients

From: Comparison and analysis of the clinicopathological features of SCEO and ECOM

  SCEO (N = 51) ECOM (N = 60) P
MEAN AGE (Y) 53.96 55.41 0.221
BMI (KG/M2) 29.31 28.93 0.245
MENOPAUSAL STATUS (PRE, POST) Pre: n = 26 (51) Pre: n = 21 (35) 0.447
Post: n = 25 (49) Post: n = 39 (65)
SERUM CA-125 LEVEL (U/ML) < 35: n = 28 (55) < 35: n = 29 (48) 0.87
> 35: n = 23 (45) > 35: n = 31 (52)
Irregular vaginal bleeding
n = 24 (47)
Irregular vaginal bleeding
n = 37 (62)
0.827
MAIN COMPLAINTS Lower abdominal mass n = 19 (37) Lower abdominal mass n = 14 (23)  
Abdominal distention n = 8 (16) Abdominal distention n = 9 (15)  
FIGO STAGE, ENDOMETRIAL CANCER I: n = 45 (88) I: n = 0 (0) 0.001
II: n = 5 (10) II: n = 0 (0)
III: n = 1 (2) III: n = 42 (70)
IV: n = 0 (0) IV: n = 18 (30)
FIGO STAGE, OVARIAN CANCER I: n = 32 (63) NA &&&
II: n = 5 (10) NA
III: n = 14 (27) NA
IV: n = 0 (0) NA
SURGERY TYPE TH + BSO: n = 2 (4) TH + BSO: n = 3 (5) 0.000
TH + BSO + PLA: n = 9 (18) TH + BSO + PLA: n = 8 (13)
TH + BSO + PLA + OM: n = 10 (20) TH + BSO + PLA + OM: n = 17 (28)
TH + BSO + OM: n = 4 (8) TH + BSO + OM: n = 6 (10)
TH + BSO + PLA + OM + PALA: n = 10 (20) TH + BSO + PLA + OM + PALA: n = 15 (25)
TH + BSO + PLA + OM + PALA+ 6: n = 4 (8) TH + BSO + PLA + OM + PALA+ 6: n = 6 (10)
TH + BSO + PLA + OM + 6: n = 8 (16) TH + BSO + PLA + OM + 6: n = 3 (5)
TH + BSO + 6: n = 1 (2) TH + BSO + 6: n = 0 (0)
TH + BSO + PLA + PALA: n = 3 (6) TPH + BSO + PLA + ALA: n = 2 (3)
HISTOLOGY TYPE Endometrioid: n = 33 (65) Endometrioid: n = 37 (62) 0.001
Not Endometrioid: n = 18 (35) Not Endometrioid: n = 23 (38)
ENDOMETRIAL TUMOUR GRADE I: n = 33 (65) I: n = 15 (25) 0.001
II-III: n = 18 (35) II-III: n = 45 (75)
MYOMETRIUM INFILTRATION DEPTH < 1/2: n = 40 (78) < 1/2: n = 22 (37) 0.001
≥1/2: n = 11 (22) ≥1/2: n = 38 (63)
LVSI (−): n = 38 (75) (−): n = 19 (32) 0.039
(+): n = 13 (25) (+): n = 41 (68)
LYMPH NODE METASTASIS (−): n = 40 (78) (−): n = 32 (53) 0.001
(+): n = 4 (8) (+): n = 20 (33)
OMENTUM METASTASIS (−): n = 30 (59) (−): n = 24 (40) 0.000
(+): n = 6 (12) (+): n = 33 (55)
POSTOPERATIVE THERAPY Follow-up: n = 0 Follow-up: n = 0 0.003
Chemotherapy: n = 18 (35) Chemotherapy: n = 29 (48)
Radiotherapy: n = 5 (10) Radiotherapy: n = 2 (4)
Chemoradiotherapy: n = 28 (55) Chemoradiotherapy: n = 29 (48)